Skip to content
  • Saturday, 22 August 2026
  • 12:50 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back
Laboratory Automation & Robotics

Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back

Lana Keisha Jul 3, 2026 0

Immunai, a pioneering startup dedicated to constructing a comprehensive foundation model of the human immune system, has significantly deepened its…

Read More
Laboratory Automation & Robotics

Immunai’s digital ‘plumbing’ keeps AstraZeneca coming back

Lana Keisha Jun 26, 2026 0

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has announced a significant expansion…

Read More
Laboratory Automation & Robotics

Immunai’s digital ‘plumbing’ keeps AstraZeneca coming back

Lana Keisha Jun 17, 2026 0

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its oncology…

Read More
Laboratory Automation & Robotics

Immunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming Back for Broader, Deeper Collaborations

Lana Keisha May 22, 2026 0

Immunai, a pioneering startup dedicated to constructing a foundational model of the human immune system, has significantly expanded its strategic…

Read More
Advancements in Alzheimer’s Disease Research Highlight Need for Subtype-Specific Treatments and Equitable Access to DiagnosticsScience News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921Amazon Bio Discovery cut MSK antibody design from a year to weeks, AWS saysInnovative Fuel Mix and Quantum Spin Polarization Could Revolutionize Fusion Energy Efficiency and Cost-Effectiveness
Japan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ